Vincenzo Canzonieri

Associate Professor of Pathology

Università degli Studi di Torino

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vincenzo Canzonieri is an Associate Professor of Pathology at Università degli Studi di Trieste, Italy. His research focuses on cutaneous melanoma, cancer therapy using nanosystems, and tumor heterogeneity in ovarian cancers. His recent publications include studies on the genetic mutation status in melanoma, chemodynamic therapy, and the prognostic implications of ADAM17 in ovarian cancer patients.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Fabio Puglisi

Head of the Unit of Medical Oncology and Cancer Prevention

ITALY

Vincenzo Canzonieri

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Clinical, Histopathological, Dermoscopic Features, and <i>BRAF</i>, <i>NRAS</i>, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma

Self-targeted nanosystem for enhanced chemodynamic cancer therapy

Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery application

Unveiling the promising anticancer activity of palladium(ii)–aryl complexes bearing diphosphine ligands: a structure–activity relationship analysis

Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy

A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area

Extramammary Paget’s Disease of the Vulva and Concomitant Premalignant/Malignant Vulvar Lesions: A Potential Challenge in Diagnosis and Treatment

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers

Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab

Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer

pCLE detects mucosal neoplastic vascular pattern in gastric linitis plastica

A Green Synthesis of Carbene-Metal-Amides (CMAs) and Carboline-Derived CMAs with Potent in vitro and ex vivo Anticancer Activity

A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor

Collaborators (16)

Fabio Puglisi

Md Mahbubur Rahman

Maria Antonietta Pizzichetta

Eros Azzalini

Giorgio Giorda

Jacopo Di Giuseppe

Delia Mezzanzanica

Andrea Ciavattini

Marina Fabbi

Serena Bonin

Gaia Goteri

Paolo Chiodini

MONICA MONTOPOLI

Daniela Califano

Andrea A. Sfriso

Flavio Rizzolio

Make your next move.